| Aug 13 |
Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts
|
| Aug 12 |
3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%
|
| Aug 11 |
Iovance's Tumor-Fighting TILs Are Just Warming Up (Rating Upgrade)
|
| Aug 10 |
Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 9 |
Why Iovance Biotherapeutics Shares Are Soaring Today
|
| Aug 9 |
Iovance soars 17% as 2024 and 2025 revenue guidance well above consensus
|
| Aug 9 |
Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
|
| Aug 9 |
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
|
| Aug 9 |
Iovance Biotherapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 9 |
Iovance Biotherapeutics, Inc. (IOVA) Q2 2024 Earnings Call Transcript
|
